Center for Reproductive Health Research Studies

If you are unsure about what studies you qualify for, simply email us at [email protected]. Alternatively, explore different UCSF studies at clinicaltrials.ucsf.edu

I'm interested in participating!

Reproductive Health Management Studies

OVA.CV Study | Longitudinal Evaluation of Ovarian Aging and Cardiovascular Risk

Status: Active, Not Enrolling New Participants
The Ovarian Aging (OVA) cohort is the largest and most ethnically diverse, community-based cohort available that can be used to determine the race/ethnic and behavioral determinants of ovarian aging and its association with CVD risk in a young cycling population. The purpose of the study is to use a longitudinal approach to evaluate markers of ovarian and cellular aging as predictors of CVD, and potentially develop new risk-reduction strategies.

We are currently not accepting any new participants.

Maritza Cárdenas
Clinical Research Coordinator
415-502-4492
[email protected]
English | Spanish

Yiu Ho Au
Clinical Research Coordinator
415-476-3514
[email protected]
English | Mandarin | Cantonese

Study Website


PRP Study | Platelet Rich Plasma for Endometrial Regeneration and Repair

Status: Active, Enrolling
Patients with intrauterine adhesions (Asherman's Syndrome) and persistent thin endometrial lining in in vitro fertilization (IVF) treatment programs, particularly those resistant to standard therapies, present a significant clinical challenge. The aim of this trial is to assess if intrauterine administration of platelet rich plasma (PRP) improves endometrial lining thickness in patients with thin lining or Asherman's Syndrome.

You may be eligible if you are: female (or assigned female at birth), aged 18-42, and diagnosed with Asherman’s Syndrome

Nik Lenhart
Clinical Research Coordinator
415-502-2555
[email protected]

Heather Huddleston MD
Principal Investigator

clinical trials Website


ACTorNOT Study | Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location

Status: Active, Enrolling
This is a randomized controlled trial to compare three currently available management strategies for women with a persisting pregnancy of unknown location (PPUL), which makes them at-risk for ectopic pregnancy. Hemodynamically stable women with a confirmed PPUL will be randomized to one of three strategies: 1) Uterine evacuation followed by methotrexate (MTX) for some (those that have evidence of a non-visualized ectopic pregnancy) 2) Empiric treatment with MTX for all 3) Expectant management.

You may be eligible if you are: female (or assigned female at birth), aged 18 years and older, and diagnosed with a persisting pregnancy of unknown location (PPUL)

Nik Lenhart
Clinical Research Coordinator
415-502-2555
[email protected]

Marcelle Cedars MD
Principal Investigator

clinical trials Website